What collagen property defect is likely causing a patient's joint connective tissue degeneration after ingesting sweet pea Lathyrus odoratus?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 3, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Defect in Collagen Cross-Linking Due to Lathyrus odoratus Ingestion

The patient's symptoms of joint connective tissue degeneration after ingesting sweet pea (Lathyrus odoratus) are most likely caused by a defect in cross-linking of collagen molecules (option A). This condition represents a form of acquired lathyrism resulting from the inhibition of lysyl oxidase enzyme activity.

Mechanism of Sweet Pea Toxicity

  • Sweet pea (Lathyrus odoratus) contains β-aminopropionitrile (BAPN), a lathyrogen that specifically inhibits lysyl oxidase, the enzyme responsible for catalyzing cross-link formation between collagen molecules 1
  • BAPN prevents the formation of cross-links between allysine residues in collagen, compromising the structural integrity of connective tissues 1, 2
  • This inhibition leads to mechanically weakened collagen that cannot withstand normal physiological stresses, resulting in joint connective tissue degeneration 1

Collagen Cross-Linking Process

  • Normal collagen strength depends on the formation of intermolecular cross-links between collagen molecules 2
  • Lysyl oxidase converts specific lysine residues to allysine, which then forms cross-links with neighboring collagen molecules 2
  • These cross-links are essential for providing tensile strength and stability to collagen fibrils in the extracellular matrix 3
  • When cross-linking is impaired, collagen fibrils become disorganized and lose their typical structural arrangement 3

Clinical Manifestations of Impaired Cross-Linking

  • Joint connective tissue degeneration is a hallmark of lathyrism due to weakened collagen structure 1
  • Skeletal deformities develop as a result of reduced mechanical integrity of the collagenous matrix 1
  • The condition may present with symptoms similar to those seen in genetic disorders affecting collagen cross-linking, such as certain forms of Ehlers-Danlos syndrome 4

Differential Diagnosis Among Answer Choices

  • Cross-linking of allysine residues (A): This is the correct answer as BAPN directly inhibits lysyl oxidase, preventing the formation of cross-links between allysine residues 1, 2
  • Glycosylation (B): While glycosylation is important for collagen function, it is not the primary target of BAPN toxicity 2
  • Hydroxylation of proline (C): Proline hydroxylation occurs earlier in collagen synthesis and is catalyzed by prolyl hydroxylase, not lysyl oxidase 2, 3
  • Primary sequence (D): The primary amino acid sequence of collagen is determined genetically and is not altered by BAPN exposure 2
  • Proteolytic processing (E): Removal of pro-peptides is necessary for collagen fibril formation but is not directly affected by BAPN 2

Clinical Implications

  • The patient's symptoms represent an acquired form of collagen dysfunction rather than a genetic disorder 1
  • Unlike genetic disorders of collagen such as osteogenesis imperfecta or Bruck syndrome, this condition is potentially reversible if exposure to the toxin is eliminated 2, 3
  • Supportive care and prevention of further exposure to the lathyrogen are the primary management approaches 1

In famine situations, consumption of Lathyrus species (including sweet peas) increases due to food scarcity, which can lead to widespread cases of lathyrism with both neurological and musculoskeletal manifestations 1.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.